Hedgehog pathway agonism: therapeutic potential and small-molecule development.
about
MRT-92 inhibits Hedgehog signaling by blocking overlapping binding sites in the transmembrane domain of the Smoothened receptor.Role of Vitamin D in Uremic Vascular Calcification.Recent advances in the design of Hedgehog pathway inhibitors for the treatment of malignancies.Canonical and non-canonical Hedgehog signalling and the control of metabolism.Regulation of the oncoprotein Smoothened by small molecules.Targeting the hedgehog signaling pathway for cardiac repair and regeneration.
P2860
Hedgehog pathway agonism: therapeutic potential and small-molecule development.
description
2013 nî lūn-bûn
@nan
2013 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Hedgehog pathway agonism: therapeutic potential and small-molecule development.
@ast
Hedgehog pathway agonism: therapeutic potential and small-molecule development.
@en
type
label
Hedgehog pathway agonism: therapeutic potential and small-molecule development.
@ast
Hedgehog pathway agonism: therapeutic potential and small-molecule development.
@en
prefLabel
Hedgehog pathway agonism: therapeutic potential and small-molecule development.
@ast
Hedgehog pathway agonism: therapeutic potential and small-molecule development.
@en
P2860
P356
P1433
P1476
Hedgehog pathway agonism: therapeutic potential and small-molecule development.
@en
P2093
M Kyle Hadden
P2860
P356
10.1002/CMDC.201300358
P577
2013-11-07T00:00:00Z